Industry insiders have observed that we are entering ‘Mushrooms 3.0’, as the category morphs from ambiguous powdered mixes into highly characterized and standardized extracts, with extensive proprietary clinical substantiation. This panel will examine the state of the science, quality tools and analytical resources – (in existence and needed) and discuss a few of the tough questions as the category seeks to define itself.
Register here: https://naturallyinformed.net/2026-supply-chain/